What is Probiusdx?
Probiusdx operates at the critical intersection of biology and artificial intelligence, providing a transformative platform that replaces traditional reagent-centric methodologies with a data-centric paradigm. By leveraging its proprietary QES technology, the company enables the precise detection and quantification of biological specimens with minimal sample requirements. This innovation is particularly significant for researchers and innovators in the biosciences sector, as it facilitates high-fidelity biomarker discovery and robust quality control. By decentralizing the collection of multidimensional biological datasets, Probiusdx effectively addresses long-standing data gaps, positioning itself as an essential infrastructure provider for modern biomedical research and pre-clinical development.
How much funding has Probiusdx raised?
Probiusdx has raised a total of $2.4M across 1 funding round:
Debt
$2.4M
Debt (2025): $2.4M, investors not publicly disclosed
Key Investors in Probiusdx
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Probiusdx?
With this major enterprise-level funding, Probiusdx is poised to accelerate its operational roadmap, focusing on the expansion of its AI-driven analytical capabilities and the broader adoption of its QES technology across global research institutions. The strategic deployment of this capital will likely prioritize the enhancement of decentralized data collection networks, enabling the company to capture a larger share of the burgeoning digital health and precision medicine markets. As the firm transitions into this next phase of growth, the focus will remain on scaling its collaborative research initiatives and solidifying its role as a foundational player in the future of biological data science.
See full Probiusdx company page
